Total Payments
$5,461
2024 Payments
$434.98
Companies
36
Transactions
253
Medicare Patients
11,140
Medicare Billing
$2.7M
Payment Breakdown by Category
Food & Beverage$5,361 (98.2%)
Education$99.98 (1.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,361 | 249 | 98.2% |
| Education | $99.98 | 4 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ACADIA Pharmaceuticals Inc | $940.00 | 32 | $0 (2024) |
| Novo Nordisk Inc | $864.67 | 16 | $0 (2022) |
| Avanir Pharmaceuticals, Inc. | $662.68 | 57 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $606.31 | 5 | $0 (2021) |
| Lilly USA, LLC | $249.64 | 16 | $0 (2023) |
| Corium, LLC | $223.15 | 6 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $217.64 | 23 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $154.54 | 9 | $0 (2024) |
| ABBVIE INC. | $151.79 | 10 | $0 (2023) |
| Astellas Pharma US Inc | $136.00 | 6 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $434.98 | 16 | ACADIA Pharmaceuticals Inc ($120.56) |
| 2023 | $992.49 | 44 | ACADIA Pharmaceuticals Inc ($278.60) |
| 2022 | $790.52 | 45 | ACADIA Pharmaceuticals Inc ($375.58) |
| 2021 | $856.90 | 55 | ACADIA Pharmaceuticals Inc ($146.30) |
| 2020 | $175.72 | 10 | Otsuka America Pharmaceutical, Inc. ($73.89) |
| 2019 | $543.21 | 13 | E.R. Squibb & Sons, L.L.C. ($245.93) |
| 2018 | $717.87 | 13 | Novo Nordisk Inc ($679.40) |
| 2017 | $949.53 | 57 | Avanir Pharmaceuticals, Inc. ($577.87) |
All Payment Transactions
253 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/11/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Neurology | ||||||
| 10/28/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $25.47 | General |
| Category: Neurology | ||||||
| 10/07/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $31.11 | General |
| 08/21/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: CNS | ||||||
| 08/12/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: PSYCHIATRY | ||||||
| 07/02/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: Respiratory | ||||||
| 05/07/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $19.66 | General |
| 05/06/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.50 | General |
| Category: PSYCHIATRY | ||||||
| 03/31/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: PSYCHIATRY | ||||||
| 03/14/2024 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $26.87 | General |
| 03/11/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $120.56 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 03/03/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: PSYCHIATRY | ||||||
| 02/06/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $24.58 | General |
| 02/05/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.50 | General |
| Category: PSYCHIATRY | ||||||
| 01/09/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $26.71 | General |
| 12/14/2023 | Sumitomo Pharma America, Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $2.24 | General |
| Category: CNS | ||||||
| 12/06/2023 | Sumitomo Pharma America, Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $8.47 | General |
| Category: CNS | ||||||
| 12/01/2023 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $25.10 | General |
| 11/30/2023 | Sumitomo Pharma America, Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $3.56 | General |
| Category: CNS | ||||||
| 11/15/2023 | Sumitomo Pharma America, Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $10.96 | General |
| Category: CNS | ||||||
| 11/14/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $116.73 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/13/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $22.67 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: Cardio-renal | ||||||
| 11/06/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $8.53 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 2,645 | 5,575 | $546,813 | $382,050 |
| 2022 | 23 | 3,909 | 6,949 | $2.3M | $1.1M |
| 2021 | 15 | 3,190 | 6,630 | $1.3M | $842,474 |
| 2020 | 10 | 1,396 | 4,320 | $397,906 | $291,309 |
Total Patients
11,140
Total Services
23,474
Medicare Billing
$2.7M
Procedure Codes
81
All Medicare Procedures & Services
81 procedure records from CMS Medicare Utilization — Page 2 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| M0223 | Intravenous injection, bebtelovimab, includes injection and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency | Office | 2022 | 153 | 153 | $251,500 | $73,365 | 29.2% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 223 | 629 | $59,038 | $42,353 | 71.7% |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | Office | 2022 | 93 | 93 | $65,100 | $37,140 | 57.1% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 262 | 654 | $46,290 | $33,624 | 72.6% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Office | 2022 | 275 | 305 | $40,238 | $28,530 | 70.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 367 | 408 | $38,133 | $26,109 | 68.5% |
| M0247 | Intravenous infusion, sotrovimab, includes infusion and post administration monitoring | Office | 2022 | 63 | 63 | $85,050 | $25,160 | 29.6% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 161 | 394 | $28,037 | $20,125 | 71.8% |
| M0245 | Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring | Office | 2022 | 49 | 49 | $34,300 | $19,569 | 57.1% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 155 | 170 | $22,715 | $16,310 | 71.8% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2022 | 227 | 251 | $22,249 | $14,652 | 65.9% |
| M0244 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital duri | Office | 2022 | 14 | 14 | $14,000 | $9,313 | 66.5% |
| 99336 | Established patient custodial care facility, group care, or assisted living visit, typically 40 minutes | Office | 2022 | 96 | 105 | $14,590 | $8,227 | 56.4% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2022 | 112 | 285 | $11,888 | $8,098 | 68.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Facility | 2022 | 32 | 32 | $5,577 | $5,003 | 89.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 97 | 111 | $6,039 | $4,288 | 71.0% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Office | 2022 | 30 | 30 | $5,095 | $3,726 | 73.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 17 | 18 | $5,171 | $3,726 | 72.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 20 | 20 | $5,916 | $3,146 | 53.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 38 | $14,030 | $2,926 | 20.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2022 | 22 | 22 | $2,988 | $2,596 | 86.9% |
| 99349 | Established patient home visit, typically 40 minutes | Office | 2022 | 12 | 25 | $6,391 | $2,320 | 36.3% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 15 | 15 | $2,574 | $1,849 | 71.9% |
| 0004A | Adm sarscov2 30mcg/0.3ml bst | Office | 2022 | 49 | 49 | $3,920 | $1,779 | 45.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 14 | 14 | $3,101 | $1,715 | 55.3% |
About Dr. Corey Finch, MD
Dr. Corey Finch, MD is a Emergency Medicine healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/03/2007. The National Provider Identifier (NPI) number assigned to this provider is 1407903644.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Corey Finch, MD has received a total of $5,461 in payments from pharmaceutical and medical device companies, with $434.98 received in 2024. These payments were reported across 253 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($5,361).
As a Medicare-enrolled provider, Finch has provided services to 11,140 Medicare beneficiaries, totaling 23,474 services with total Medicare billing of $2.7M. Data is available for 4 years (2020–2023), covering 81 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Other Specialties Family Medicine
- Location Oklahoma City, OK
- Active Since 01/03/2007
- Last Updated 10/23/2024
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1407903644
Products in Payments
- NUPLAZID (Drug) $940.00
- NUEDEXTA (Drug) $633.15
- ELIQUIS (Drug) $606.31
- Tresiba (Drug) $431.07
- Ozempic (Drug) $239.34
- REXULTI (Drug) $209.51
- APTIOM (Drug) $159.01
- Kerendia (Drug) $130.27
- Victoza (Drug) $118.84
- Azstarys (Drug) $116.73
- TRULICITY (Drug) $115.58
- TOUJEO (Drug) $99.99
- GEMTESA (Drug) $97.12
- KYNMOBI (Drug) $93.09
- Adlarity (Drug) $91.05
- UBRELVY (Drug) $77.85
- ENTRESTO (Drug) $69.86
- CAPLYTA (Drug) $62.41
- MYRBETRIQ (Drug) $61.01
- SPRAVATO (Drug) $60.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Oklahoma City
Alexander Frank, M.d, M.D
Emergency Medicine — Payments: $3.1M
Emergency Medicine $3.1M
Mohammad Razaq, M.d, M.D
Emergency Medicine — Payments: $177,813
Emergency Medicine $177,813
Jose Borrego Acosta, Md, MD
Emergency Medicine — Payments: $76,213
Emergency Medicine $76,213
Lindsey Epperson
Emergency Medicine — Payments: $36,931
Emergency Medicine $36,931
Dr. Tyson Quy, M.d, M.D
Emergency Medicine — Payments: $35,983
Emergency Medicine $35,983
Michael Partin, M.d, M.D
Emergency Medicine — Payments: $10,117
Emergency Medicine $10,117